DEF 14A
BIOMARIN PHARMACEUTICAL INC. PROXY
- Company
- BIOMARIN PHARMACEUTICAL INC
- Filed
- April 28, 2000
- Period of Report
- December 31, 1999
- Accession Number
- 0001048477-00-000009
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →